CAT and hepatocellular carcinoma: Thus, low catalase expression in tumors compared to non-tumor tissues could serve as a valuable predictor of poor survival of patients with advanced HCC, and enhancement of catalase expression in tumors could be a useful therapeutic strategy for the treatment of HCC.